C260-3433 Screening compound: 1-{[(2-methoxyphenyl)carbamoyl]methyl}-2,4-dioxo-3-[(oxolan-2-yl)methyl]-N-(2-phenylethyl)-1,2,3,4-tetrahydroquinazoline-7-carboxamide

C260-3433 Screening compound: 1-{[(2-methoxyphenyl)carbamoyl]methyl}-2,4-dioxo-3-[(oxolan-2-yl)methyl]-N-(2-phenylethyl)-1,2,3,4-tetrahydroquinazoline-7-carboxamide
C260-3433 Screening compound: 1-{[(2-methoxyphenyl)carbamoyl]methyl}-2,4-dioxo-3-[(oxolan-2-yl)methyl]-N-(2-phenylethyl)-1,2,3,4-tetrahydroquinazoline-7-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C260-3433
1-{[(2-methoxyphenyl)carbamoyl]methyl}-2,4-dioxo-3-[(oxolan-2-yl)methyl]-N-(2-phenylethyl)-1,2,3,4-tetrahydroquinazoline-7-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C260-3433

Molecular Formula

C31H32N4O6 (C31 H32 N4 O6)

Compound Name

1-{[(2-methoxyphenyl)carbamoyl]methyl}-2,4-dioxo-3-[(oxolan-2-yl)methyl]-N-(2-phenylethyl)-1,2,3,4-tetrahydroquinazoline-7-carboxamide

IUPAC name

1-{[(2-methoxyphenyl)carbamoyl]methyl}-24-dioxo-3-[(oxolan-2-yl)methyl]-N-(2-phenylethyl)-1234-tetrahydroquinazoline-7-carboxamide

SMILES

COc(cccc1)c1NC(CN(c(cc(cc1)C(NCCc2ccccc2)=O)c1C(N1CC2OCCC2)=O)C1=O)=O

InChI

InChI=1S/C31H32N4O6/c1-40-27-12-6-5-11-25(27)33-28(36)20-34-26-18-22(29(37)32-16-15-21-8-3-2-4-9-21)13-14-24(26)30(38)35(31(34)39)19-23-10-7-17-41-23/h2-6,8-9,11-14,18,23H,7,10,15-17,19-20H2,1H3,(H,32,37)(H,33,36)/t23-/m1/s1

InChI Key

OXJVZGOIWRUYTP-HSZRJFAPSA-N

MDL Number (MFCD)

MFCD14739168

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

556.62

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.788

Distribution Coefficient, logD

2.788

Water Solubility, LogSw

-3.57

Polar Surface Area

94.258

Acid Dissociation Constant (pKa)

11.40

Base Dissociation Constant (pKb)

2.97

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

29.00

C260-3433 in Drug Discovery

Included in Screening Libraries

Nucleoside Mimetics Library (2197 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Cancer
  • Immune system
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with C260-3433 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C260-3433?
Check Price and Availability of C260-3433, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C260-3433 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C260-3433
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C260-3433
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C260-3433 available by request